SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nippon India Mutual Fund acquires stake in Sanofi India

15 Jun 2026 Evaluate

Nippon India Mutual Fund has acquired stake in Sanofi India through an open market transaction worth around Rs 83.19 crore. The mutual fund has acquired around 2.64 lakh shares, representing 1.15% of total shareholding, of the company. The shares were acquired at an average price of Rs 3,150 apiece. 

Meanwhile, HDFC Life Insurance Company has sold 2.75 lakh shares, representing 1.19% of total shareholding, of the company at the same price.

Sanofi India primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.

Sanofi India Share Price

3346.95 -17.80 (-0.53%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: